Leading GLP-1 Medications : Semaglutide: Marketed as Ozempic (for type 2 diabetes) and Wegovy (for weight loss), semaglutide has demonstrated significant efficacy in weight management
Additionally, Retatrutide enhances protein synthesis & inhibits protein degradation, thereby promoting muscle hypertrophy & reducing muscle wasting
Common side effects include nausea and gastrointestinal symptoms
A classification of diabetes management drugs commonly known as GLP-1 agonists have specifically contributed to a spike in health insurance spending from 2022 to 2023, the costs for GLP-1 drugs paid on behalf of our members grew by more than $350 million
To get the most from your GLP-1 medication: Understand the difference between normal progression and potential issues: Normal experiences: Signs to consult your provider: GLP-1 medications are powerful tools for weight management, but they work gradually and in partnership with lifestyle changes
Conversely, some patients may experience fatigue as a side effect, leading to reduced activity and subsequent joint stiffness